Altrinsic Global Advisors’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-216,500
Closed -$1.62M 70
2021
Q4
$1.62M Hold
216,500
0.05% 61
2021
Q3
$1.95M Hold
216,500
0.06% 65
2021
Q2
$2.59M Hold
216,500
0.08% 60
2021
Q1
$2.71M Hold
216,500
0.09% 58
2020
Q4
$3.38M Sell
216,500
-200,000
-48% -$3.12M 0.11% 49
2020
Q3
$3.94M Hold
416,500
0.16% 46
2020
Q2
$3.73M Hold
416,500
0.16% 47
2020
Q1
$2.65M Hold
416,500
0.15% 47
2019
Q4
$3.49M Hold
416,500
0.15% 45
2019
Q3
$3.77M Hold
416,500
0.16% 46
2019
Q2
$4.49M Hold
416,500
0.21% 45
2019
Q1
$3.97M Buy
416,500
+36,500
+10% +$348K 0.18% 47
2018
Q4
$4.36M Buy
380,000
+70,000
+23% +$804K 0.21% 47
2018
Q3
$5.26M Buy
310,000
+50,000
+19% +$848K 0.24% 46
2018
Q2
$3.69M Buy
260,000
+50,000
+24% +$710K 0.15% 56
2018
Q1
$3.99M Sell
210,000
-140,000
-40% -$2.66M 0.16% 51
2017
Q4
$5.74M Sell
350,000
-190,000
-35% -$3.12M 0.22% 44
2017
Q3
$8.1M Sell
540,000
-40,000
-7% -$600K 0.31% 44
2017
Q2
$5.1M Sell
580,000
-50,000
-8% -$440K 0.18% 55
2017
Q1
$3.28M Hold
630,000
0.11% 62
2016
Q4
$1.92M Hold
630,000
0.07% 68
2016
Q3
$2.92M Buy
630,000
+130,000
+26% +$602K 0.11% 63
2016
Q2
$2.9M Hold
500,000
0.08% 65
2016
Q1
$3.03M Buy
500,000
+10,000
+2% +$60.5K 0.08% 69
2015
Q4
$4.47M Hold
490,000
0.12% 65
2015
Q3
$2.76M Buy
490,000
+150,000
+44% +$846K 0.06% 70
2015
Q2
$3.77M Hold
340,000
0.08% 68
2015
Q1
$5.33M Hold
340,000
0.12% 60
2014
Q4
$5.17M Hold
340,000
0.11% 57
2014
Q3
$3.67M Hold
340,000
0.07% 67
2014
Q2
$5.19M Buy
340,000
+100,000
+42% +$1.53M 0.09% 65
2014
Q1
$4.34M Sell
240,000
-40,000
-14% -$723K 0.07% 71
2013
Q4
$3.89M Buy
280,000
+40,000
+17% +$556K 0.07% 64
2013
Q3
$2.52M Hold
240,000
0.04% 68
2013
Q2
$1.87M Buy
+240,000
New +$1.87M 0.03% 67